Neurology at Huashan Hospital Shanghai | CMCS

China's Number One Neurology Department

The Department of Neurology at Huashan Hospital — affiliated with Fudan University — is consistently ranked as the number one neurology department in China, and is recognized internationally as one of Asia's most distinguished centers for the diagnosis and management of neurological diseases. With unparalleled expertise spanning cerebrovascular disease, Parkinson's disease and movement disorders, dementia and cognitive neurology, neuroimmunology, epilepsy, neuromuscular disease, and headache, the department offers comprehensive, evidence-based neurological care delivered by some of China's most eminent neurologists.

For international patients with neurological conditions — whether seeking expert diagnosis, a second opinion on a complex neurological presentation, or access to the latest treatments for Parkinson's disease, multiple sclerosis, or a rare neurological disorder — Huashan Hospital's neurology department represents the gold standard of neurological care in China. China Medical Concierge Shanghai (CMCS) provides seamless end-to-end coordination for international patients throughout their care journey.

About the Department

Huashan Hospital's neurology department is a national key clinical specialty and the top-ranked neurology department in China's national hospital ranking system for over a decade. The department operates dedicated inpatient neurology wards, a stroke unit, a neurology intensive care unit (NICU), a comprehensive neurophysiology laboratory, a neuroimaging center, a memory and cognitive disorders clinic, a movement disorders clinic, a neuroimmunology and multiple sclerosis clinic, an epilepsy monitoring unit, a neuromuscular disease clinic, and a headache center.

The department's research program is one of the most productive in Chinese neurology, with faculty members publishing regularly in the world's leading neurology journals including New England Journal of Medicine, Lancet Neurology, Brain, Annals of Neurology, JAMA Neurology, and Neurology. The department participates actively in national and international clinical trials, providing patients with access to cutting-edge investigational therapies.

Conditions Treated

Cerebrovascular Disease

• Ischemic Stroke — Hyperacute management including IV thrombolysis (tPA) and mechanical thrombectomy; stroke unit care; secondary prevention; cryptogenic stroke workup
• Hemorrhagic Stroke — Intracerebral hemorrhage and subarachnoid hemorrhage management; neurosurgical coordination
• Transient Ischemic Attack (TIA) — Urgent evaluation and secondary prevention to prevent stroke
• Cerebral Venous Thrombosis — Anticoagulation and management of raised intracranial pressure
• Carotid Artery Disease — Carotid endarterectomy and stenting coordination; intracranial atherosclerosis management
• Small Vessel Disease & Vascular Cognitive Impairment — Risk factor management and cognitive rehabilitation

Movement Disorders

• Parkinson's Disease — Comprehensive management from early to advanced disease; optimized dopaminergic therapy; deep brain stimulation (DBS) coordination; non-motor symptom management
• Atypical Parkinsonism — MSA, PSP, CBS, and DLB; expert differential diagnosis and management
• Essential Tremor — Medical management and DBS/focused ultrasound coordination
• Dystonia — Botulinum toxin injection; DBS for generalized dystonia
• Huntington's Disease — Genetic counseling, symptomatic management, and clinical trial access
• Wilson's Disease — Copper chelation therapy and liver disease coordination
• Restless Legs Syndrome — Dopaminergic and non-dopaminergic therapy; augmentation management

Dementia & Cognitive Neurology

• Alzheimer's Disease — Comprehensive diagnostic workup including amyloid PET, CSF biomarkers (Aβ42, tau, p-tau), and MRI volumetry; cholinesterase inhibitors and memantine; lecanemab and donanemab for early AD (clinical trial access)
• Frontotemporal Dementia — Expert diagnosis of FTD subtypes (bvFTD, PPA, PSP, CBS); genetic testing for GRN, MAPT, C9orf72
• Lewy Body Dementia — Diagnosis and management of DLB and PDD; neuroleptic sensitivity counseling
• Vascular Dementia — Risk factor management and cognitive rehabilitation
• Mild Cognitive Impairment (MCI) — Biomarker-guided risk stratification; lifestyle intervention and clinical trial access
• Rapidly Progressive Dementia — Urgent workup for prion disease, autoimmune encephalitis, and other treatable causes

Neuroimmunology & Demyelinating Disease

• Multiple Sclerosis (MS) — Comprehensive MS management; full range of disease-modifying therapies (interferons, glatiramer, natalizumab, ocrelizumab, ofatumumab, cladribine, alemtuzumab); JC virus monitoring; highly active MS management
• Neuromyelitis Optica Spectrum Disorder (NMOSD) — AQP4-IgG and MOG-IgG testing; inebilizumab, satralizumab, and eculizumab for AQP4-positive NMOSD
• MOG Antibody-Associated Disease (MOGAD) — Diagnosis and management of MOG-IgG positive optic neuritis, ADEM, and myelitis
• Autoimmune Encephalitis — Anti-NMDAR, anti-LGI1, anti-CASPR2, and other autoimmune encephalitides; immunotherapy and tumor search
• Neurosarcoidosis — Diagnosis and immunosuppressive management
• CNS Vasculitis — Primary angiitis of the CNS; diagnosis and immunosuppression

Epilepsy

• New-Onset Epilepsy — Comprehensive diagnostic workup; antiseizure medication selection based on seizure type and syndrome
• Drug-Resistant Epilepsy — Presurgical evaluation; video-EEG monitoring; stereo-EEG (SEEG) for seizure focus localization; surgical referral
• Status Epilepticus — Emergency management of convulsive and non-convulsive status epilepticus
• Genetic Epilepsies — Genetic testing and precision therapy (e.g., quinidine for KCNT1, fenfluramine for Dravet syndrome)
• Autoimmune Epilepsy — Antibody testing and immunotherapy

Neuromuscular Disease

• Myasthenia Gravis — AChR and MuSK antibody testing; pyridostigmine, immunosuppression, eculizumab, efgartigimod, and rozanolixizumab; thymectomy coordination
• Guillain-Barré Syndrome — IVIG and plasma exchange; respiratory monitoring and ICU coordination
• Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) — IVIG, corticosteroids, and efgartigimod
• Amyotrophic Lateral Sclerosis (ALS) — Multidisciplinary ALS clinic; riluzole, edaravone, and tofersen; respiratory and nutritional support
• Muscular Dystrophies — Genetic diagnosis and multidisciplinary management; exon-skipping therapy for Duchenne MD
• Peripheral Neuropathy — Comprehensive electrodiagnostic evaluation; diabetic, hereditary, and inflammatory neuropathies
• Spinal Muscular Atrophy (SMA) — Nusinersen, risdiplam, and onasemnogene abeparvovec therapy

Headache

• Migraine — Acute and preventive therapy; CGRP monoclonal antibodies (erenumab, fremanezumab, galcanezumab) for chronic migraine; gepants and ditans for acute treatment
• Cluster Headache — Acute oxygen therapy and triptans; verapamil and lithium prophylaxis; galcanezumab for episodic cluster headache
• Idiopathic Intracranial Hypertension — Acetazolamide, weight management, and CSF diversion coordination
• Trigeminal Neuralgia — Carbamazepine and oxcarbazepine; neurosurgical referral for MVD

Neurophysiology & Diagnostic Capabilities

Huashan's comprehensive neurophysiology laboratory provides the full range of diagnostic testing for neurological conditions:

• EEG & Video-EEG Monitoring — Routine, prolonged, and inpatient video-EEG for epilepsy diagnosis and presurgical evaluation
• Nerve Conduction Studies & EMG — Comprehensive electrodiagnostic evaluation for neuromuscular disease
• Evoked Potentials — VEP, BAEP, and SSEP for MS, optic neuritis, and spinal cord disease
• Transcranial Magnetic Stimulation (TMS) — Cortical excitability assessment and therapeutic applications
• Autonomic Function Testing — For dysautonomia, MSA, and diabetic autonomic neuropathy
• CSF Analysis — Comprehensive CSF biomarkers including AD biomarkers (Aβ42, tau, p-tau181), oligoclonal bands, and autoimmune antibody panels
• Neurogenetics — Comprehensive genetic testing panels for hereditary neurological diseases

Why International Patients Choose Huashan Neurology

• China's #1 Neurology Department — Consistently top-ranked for over a decade; the definitive destination for complex neurological diagnosis and management in China
• Comprehensive Subspecialty Expertise — Dedicated clinics for every major neurological subspecialty under one roof
• Cutting-Edge Therapies — Early access to novel therapies including anti-amyloid therapy for Alzheimer's, CGRP antibodies for migraine, and novel MS disease-modifying therapies
• Autoimmune Neurology Leadership — National expertise in MS, NMOSD, MOGAD, and autoimmune encephalitis
• Neuromuscular Disease Expertise — Comprehensive electrodiagnostic and genetic capabilities for rare neuromuscular conditions
• Cost-Effectiveness — World-class neurological care at significantly lower cost than equivalent treatment in Western countries

The CMCS Patient Journey

1. Initial Inquiry — Share your neurological history, MRI/CT reports, EEG results, CSF analysis, neurophysiology studies, and current medications with CMCS.
2. Medical Record Preparation — We translate and organize your records for specialist pre-consultation review.
3. Specialist Matching — We identify the most appropriate neurologist based on your condition — stroke, movement disorders, dementia, MS, epilepsy, neuromuscular disease, or headache.
4. Priority Scheduling — We secure a consultation with minimal waiting time.
5. Travel & Logistics — Assistance with visa invitation letters, accommodation near Huashan Hospital, and Shanghai airport transfers.
6. On-Site Concierge — Bilingual coordinators accompany you throughout your hospital visits, managing registration, translation, and communication.
7. Diagnostic Support — Full coordination of MRI, EEG, EMG, CSF analysis, genetic testing, and other required investigations.
8. Post-Treatment Follow-Up — Test result translation, treatment plan interpretation, and remote follow-up coordination after you return home.

Book a Consultation

If you are seeking expert neurological care in Shanghai — whether for stroke, Parkinson's disease, dementia, multiple sclerosis, epilepsy, neuromuscular disease, migraine, or a rare neurological condition — CMCS can arrange a specialist consultation with Huashan Hospital's world-renowned neurology team.

📧 contract@medicalsh.com
💬 WhatsApp: https://wa.me/message/3AM6KAGCW2BAD1
🌐 www.medicalsh.com